The Federal Trade Commission (FTC) announced on June 30th a new notice of proposed rulemaking (NPRM) that attempts to stop marketers from using illicit or deceptive review and endorsement practices. This proposed rule aims to protect consumers seeking genuine feedback on products and services while promoting fairness for honest businesses. Any agencies or their clients […]
Read more The Federal Trade Commission (FTC) issued updates on June 29, 2023 to its Guides Concerning the Use of Endorsements and Testimonials in Advertising (“Endorsement Guides”) and updated its practical business guidance “FTC’s Endorsement Guides: What People are Asking” (“Business Guidance”). Last updated in 2009, the final revisions to the Endorsement Guides feature several key additions addressing technological changes in […]
Read more
On May 30, National Labor Relations Board (NLRB) General Counsel Jennifer Abruzzo sent a memo to all Regional Directors, Officers-in-Charge, and Resident Officers, deeming that the act of extending, maintaining, and enforcing of non-compete provisions in employment contracts and severance agreements seemingly violates the National Labor Relations Act (NLRA) except in limited circumstances. NLRB General Counsel Abruzzo’s […]
Read more
Aug. 22, 2022 – For years, the issue of regulating data privacy has been addressed largely by individual states, with little comprehensive action on the federal level. But that may be about to change in light of a more aggressive Federal Trade Commission (FTC), a new bipartisan proposal in Congress, and the U.S. Supreme Court’s […]
Read more
May 4, 2020 – An important part of protecting the public health during the COVID-19 pandemic is making sure that the marketing of treatments or remedies that are not approved by the Food and Drug Administration (FDA) to treat the virus is stopped before consumers waste their money or potentially are harmed by these products. […]
Read more
April 13, 2020 – The Food and Drug Administration (FDA) is responding to the challenges of COVID-19 in new ways that streamline product review and policy approaches, while also ensuring that entities promoting unapproved products that claim to be effective against the virus do not go unchecked. Last week, the FDA and the Federal Trade […]
Read more
March 16, 2020 – Amid rising concerns over “Novel Coronavirus Disease 2019” (COVID-19), the Food and Drug Administration and the Federal Trade Commission took action last week against seven companies for selling fraudulent COVID-19 products. The regulators sent Warning Letters to the companies because these products “are unapproved drugs that pose significant risks to patient […]
Read more
Feb. 19, 2019 – In a move that “merits industry attention,” the Federal Trade Commission (FTC) announced last week that it had joined the Food and Drug Administration (FDA) in enforcement actions against three companies advertising that their products can treat diseases like Alzheimer’s, according to a Feb. 11 post by Lesley Fair, senior attorney, […]
Read more
Feb. 12, 2018 – The Federal Trade Commission (FTC) and the Maine Attorney General announced a $2 million settlement Feb. 6 against Marketing Architects Inc., an ad agency that “created and disseminated allegedly deceptive radio ads for weight-loss products marketed by its client, Direct Alternatives,” according to the FTC. Marketing Architects also provided interactive voice […]
Read more